Yohta Shimada
Tokyo, 1058461, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Adeno-associated virus expressing a blood-brain barrier-penetrating enzyme improves GM1 gangliosidosis in a preclinical model.
Journal: The Journal of clinical investigation
Published: March 04, 2024
Usefulness of antibody-drug conjugate as preconditioning for hematopoietic stem cell-targeted gene therapy in wild-type and Fabry disease mouse models.
Journal: Molecular genetics and metabolism
Published: March 01, 2024
Restoration of peripheral neuropathy in Fabry mice via intrathecal administration of an adeno-associated virus vector encoding mGLA cDNA.
Journal: Molecular genetics and metabolism
Published: March 01, 2024
Erratum: Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis.
Journal: Molecular therapy. Methods & clinical development
Published: October 03, 2022
Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis.
Journal: Molecular therapy. Methods & clinical development
Published: November 30, 2021
Inhibition of lysosomal acid β-glucosidase induces cell apoptosis via impairing mitochondrial clearance in pancreatic cancer.
Journal: Carcinogenesis
Published: September 21, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Journal: Autophagy
Published: February 26, 2021
Suppression of lysosomal acid alpha-glucosidase impacts the modulation of transcription factor EB translocation in pancreatic cancer.
Journal: Cancer science
Published: November 28, 2020
Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy.
Journal: Molecular genetics and metabolism
Published: April 10, 2020
Ex Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling Reactivation.
Journal: Molecular therapy. Methods & clinical development
Published: February 07, 2020
Last Updated: 09/26/2026